Independent. No tobacco money. No corporate fluff.THU, OCT 8

PouchDaily

The daily pulse of the nicotine pouch market

Regulation
GermanyEuropean Union

Germany's medical establishment tells the government: keep the pouch ban

A broad alliance of German medical associations, led by the Bundesärztekammer, has formally appealed to the government to keep the ban on nicotine pouch sales — direct pushback against industry calls to legalize and tax pouches for over €200 million a year.

PouchDaily Desk·
Germanynicotine pouchesregulationBundesärztekammerlegalizationyouthBfRBIÖG

A broad alliance of German medical associations and health organizations has formally appealed to the federal government to keep the ban on selling nicotine pouches in Germany — a direct strike against the tobacco industry's push to legalize, regulate and tax the products. The appeal, published by the Bundesärztekammer (German Medical Association) on 14 September 2026, carries a blunt headline: "Kein Verkauf von Nikotinbeuteln in Deutschland" — no sales of nicotine pouches in Germany.

What happened

Germany currently blocks nicotine pouch sales because the products are classified as novel foods ("neuartige Lebensmittel"). The Bundesärztekammer alliance says that ban must stay. In its own words, lifting it would increase the availability, visibility and marketing potential of the products and make it easier to enter nicotine use — especially for people whom other tobacco and nicotine products have never appealed to.

The appeal leans on two official data points:

  • Youth reach. Citing the Federal Institute for Public Health (BIÖG), 5.5% of 12- to 17-year-olds and 18.9% of 18- to 25-year-olds in Germany had tried nicotine pouches as of 2025 — despite the ban.
  • Nicotine dose. Citing the Federal Institute for Risk Assessment (BfR), pouches can raise blood nicotine to levels comparable to cigarette smoking, and nicotine poses addiction and cardiovascular risks.

The alliance includes the German Medical Association, medical specialty societies and health organizations; the German Hospital Federation (Deutsche Krankenhausgesellschaft) published the joint call on 15 September. The appeal follows dpa-distributed coverage in which the Saxon State Medical Chamber's president, Erik Bodendieck, called legalization a serious mistake for youth health, and Leipzig University Hospital's Katja Leuteritz reported rising numbers of people seeking help for pouch-related nicotine use.

Why it matters

The industry side is not standing still. Jan Mücke, speaking for the tobacco industry, argues the ban is ineffective because the products are freely available in neighboring countries and online, and claims legalization would bring in over €200 million in annual tax revenue. That figure sits in the same debate the Bundestag's own research service fed in August, when it estimated the grey market costs the state up to €368 million a year in lost tax on roughly 1.5 million regular users.

So Germany's decision now has a well-organized health block and a well-organized industry block staring at each other. Green Party politician Paula Piechotta has voiced skepticism about the tax argument, noting some schools already ban the products outright — a sign the political coalition for legalization is not settled.

What's next

The appeal targets the federal government, so the ball is in Berlin's court. Watch for three things: whether the coalition advances any legalization framework in the Bundestag, whether enforcement against the existing online grey market tightens instead, and how Germany's stance shapes the EU-level conversation on pouch regulation. For now, one thing is fixed: the people who advise German doctors and hospitals on health policy want the ban kept exactly where it is.

SOURCES:

Compare nicotine pouch brands and prices at PouchFinder.